HIV Part 3 Flashcards

1
Q

What are the 2 drugs in the version of PrEP that is generic and covered by public health (not the new version recently approved in 2020).

A

TDF 300 mg (Tenofovir disoproxil
fumarate) + FTC 200 mg (Emtricitabine)

new version: (TAF/FTC approved Dec 2020)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is PrEP dosed?

A

Dose: 1 tablet daily (TDF/FTC) with or
without food

[alternative dosing strategy
“PrEP on demand”]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the CrCL threshold for PreP?

A

not recommended if crCL < 60 mL/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

IF HIV status is positive or unknwon, should you give PrEP?

A

no! PrEP not appropriate if unknown or
positive HIV status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how effecitve is prep if adhernet?

A

> 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the PrEP Eligibility criteria for:
1) MSM, Trans Women and Gender Diverse
People?

A

– Condomless anal sex within last 6 months and any
of:
* Infectious syphilis or bacterial STI in past 12 months
* nPEP (post exopsure porphylaxis) more than once
* Ongoing sexual relationship with HIV+ partner with
substantial risk of transmissable HIV (e.g. VL detectable
or HIV status unknown but from higher risk population –
MSM or PWID)
* HIRI-MSM risk score ≥ 11 (see resources)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

According to the HIRI-MSM risk assessment toosl, what are the two HIGHEST RISK CATEGORIES?

A

young age and receptive anal sex in the last 6 months wihtout a condom.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the PrEP Eligibility criteria for:
2) Heterosexual persons?

A

For HIV negative partner in an ongoing
relationship with HIV positive partner involving
condomless vaginal/anal sex where HIV positive
partner has substantial risk of transmissible HIV
(e.g. VL> 40 copies/mL)
OR
HIV status unknown
but they’re from a higher risk population (e.g. MSM, PWID).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the PrEP Eligibility criteria for:
3) People who inject drugs

A

if they shareinjection drug use paraphernalia (e.g.,
needles, syringes, etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does PrEP work?

A

it prevents HIV from continuing to infect immune cells and getting established early on (i.e. prevents seeding to rest of body).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How long does PREP take to establish protective levels of drug in rectal tissue? vaginal tissue?

A

– Rectal tissue – 7 days
– Vaginal tissue – 20 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the things to ASSESS FOR ELIGIBILITY FOR PREP?

  • Individual is HIV _______ but at ____ risk of _________
  • No signs/symptoms of __________ in previous ______
  • No documented ____________ to FTC/TDF
  • what lab tests/screenings to order? (3)
A
  • Individual is HIV negative (recent test) and is at high risk of acquiring HIV infection
  • No signs/symptoms of acute HIV in previous month
  • No documented contraindications to FTC/TDF

–> Other laboratory tests:
* Screening for HBV (vaccinate if susceptible), and HCV
* STI screening
* CBC, Scr, urinalysis at baselin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Can anyone prescribe prep?

A

no! Must be prescribed by a designated prescriber (AB).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many days duration should the INITAL PRESCRIPTION OF PREP BE?

A
  • for 30 days (NO automatic refills, cuz imp to get follow up blood work done***).
    • If runs out of med, see when last had screening done, reach out to doc etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some counselling points for STARTING PREP?

1) Discuss can take 7 days (or 20 days) to reach ___________

2) Review ___________:
* Common ones?
* Other 2 imp ones?

3) Review if patient taking other drugs that may incr risk of ___ toxicity.

4) Reinforce/discuss strategies for ______.

A

1) Discuss can take 7 days (or 20 days) to reach protective concentrations

2) Review Adverse events:
* Common – headache, abdominal pain, flatulence
* Other – decreased renal function, decreased BMD

3) Review if patient taking other drugs that may increase risk of TDF renal toxicity

4) Reinforce/discuss strategies for adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How often should you be following up PREP pts?

A

at least q3 months.
–> (follow-up HIV & STI testing every 3 months)

17
Q

You should Refill a prescription for PREP no more than ___ days

A

Refill prescription for no more than 90 days
–> Requests for refill extension – discuss with designated prescriber (case by case basis)

18
Q

What should PREP pts of childbearing potential be continually monitored/tested for?

A

should have regular pregnancy tests.

19
Q

What is Post-Exposure Porphylaxis (PEP)?

A

– Combination antiretroviral therapy (cART) given to someone who may have been exposed to HIV –> usually 2- or 3-drug regimens used to prevent acquisition of HIV infection.

20
Q

How soon should PEP/cART be given from time of exposure?

A

ASAP, and within 72 hrs. beyond that, useless and must refer to ED.

21
Q

What is the preferred regimen for PEP?
- what is the “3rd drug”?
- duration?

A

-Truvada (tenofovir/emtricitabine) 1 tab daily.
- 3rd drug: Raltegravir 400 mg BID OR Dolutegravir 50 mg daily.
> Duration: x 28 days.

22
Q

Are occupational and non-occupational HIV exposures covered?

A

yes. In Alberta, occupational exposures covered by employer (e.g.AHS) and non-occupational exposures covered by Alberta Health

23
Q

What is the rate of perinatal HIV transmission w/o trx?

A

25%

24
Q

80% of perinatal hiv transmission occurs at what point durign prengnacy?

A

just before or DURING delivery (cuz exchange of blood).

25
Q

Acquiring HIV when is asociated with the HIGHEST RISK for in-utero transmission?

A

Acquiring HIV DURING pregnancy is asociated with the HIGHEST RISK for in-utero transmission.

26
Q

What is the risk of hiv transmission from breastfeeding in untreated mothers?

A

0.5%.

27
Q

what is risk of perinatal transmission in ART treated women?

A

close to 0 if can get VL < 50.

28
Q

Are Antivirals safe in pregnancy?

A

yesss

29
Q

PREVENTING PERINATAL HIV:

  • HOw should pregnant women be treated:
  • before delivery?
  • during Labor nad Delivery?
    –> only when should you consider C section?
  • after delivery?
  • What is the baby’s prophylaxis regimen?
  • should baby be breastfed?
A

PREVENTING PERINATAL HIV:

  • Pregnant Person:
    – Testing (opt-out; rapid HIV testing at delivery where
    appropriate)

– BEFORE DELIVERY: should be on Antiretrovirals (ARVs) during pregnancy
(ideally before pregnancy).–> Goal: suppressed viral load.

– DURING L & D: During labour, give IV zidovudine + continue oral ARVs for the mother.

  • Consider C-section ONLY if VL> 1000 copies/mL close to delivery.

– AFTER DELIVERY: Mother should Continue ARVs

  • Baby:
    – shoudl be started on ARV prophylaxis: oral zidovudine x 4-6 wks (start within 6 hours)

– should be FORMULA FED (cuz- risk of
transmission via breastfeeindg < 1% but not zero)

30
Q

What is the preferred AV drugs in pregnancy (if not previously on trx)?

  • what are the 2 options for the third drug?
A

Preferred Dual NRTI backbone:
▪ Abacavir/lamivudine
▪ Tenofovir DF + emtricitabine or lamivudine
▪ Tenofovir alafenamide/emtricitabine

3rd drug:
▪ INSTI – dolutegravir
▪ PI –darunavir/ritonavir